Cancer nurses in the United Kingdom are reportedly being exposed to “hazardous” medicines linked to an increased risk of ...
Cytokinetics reported that its drug aficamten significantly improved symptoms in patients with non-obstructive hypertrophic cardiomyopathy, advancing prospects for FDA approval. In parallel, Wolfson ...
GLP-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists are not likely to decrease the ...
A lower-court ruling had reinstated a Food and Drug Administration requirement that patients visit a health care provider in ...
GLP-1 drugs are becoming popular lately for their effectiveness in weight management and type 2 diabetes control A recent ...
Scientists have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect. Scientists at the Icahn School of Medicine at Mount Sinai and ...